From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment.
about
The ketamine analogue methoxetamine and 3- and 4-methoxy analogues of phencyclidine are high affinity and selective ligands for the glutamate NMDA receptorKynurenines in CNS disease: regulation by inflammatory cytokinesPharmacology of hallucinations: several mechanisms for one single symptom?Functional profile of a novel modulator of serotonin, dopamine, and glutamate neurotransmissionChemical modulation of mutant mGlu1 receptors derived from deleterious GRM1 mutations found in schizophrenicsEffect of Pharmacological Interventions on the Fronto-Cingulo-Parietal Cognitive Control Network in Psychiatric Disorders: A Transdiagnostic Systematic Review of fMRI StudiesFollowing the genes: a framework for animal modeling of psychiatric disordersAntidepressant actions of ketamine: from molecular mechanisms to clinical practiceWindows to the soul: vision science as a tool for studying biological mechanisms of information processing deficits in schizophreniaRole of nucleus accumbens glutamatergic plasticity in drug addictionEmerging approaches for treatment of schizophrenia: modulation of glutamatergic signalingPrenatal immune challenge in rats: effects of polyinosinic-polycytidylic acid on spatial learning, prepulse inhibition, conditioned fear, and responses to MK-801 and amphetamine.Gsx1 expression defines neurons required for prepulse inhibition.Emotional and cognitive dysregulation in schizophrenia and depression: understanding common and distinct behavioral and neural mechanismsXanthurenic Acid Activates mGlu2/3 Metabotropic Glutamate Receptors and is a Potential Trait Marker for SchizophreniaPrevalence of anti-N-methyl-D-aspartate (NMDA) receptor [corrected] antibodies in patients with schizophrenia and related psychoses: a systematic review and meta-analysisANKS1B Gene Product AIDA-1 Controls Hippocampal Synaptic Transmission by Regulating GluN2B Subunit LocalizationShank3 deficiency induces NMDA receptor hypofunction via an actin-dependent mechanismNeuregulin 1 Prevents Phencyclidine-Induced Behavioral Impairments and Disruptions to GABAergic Signaling in MiceRepurposing Drugs for Cognition in Schizophrenia.Schizophrenia.nAChR dysfunction as a common substrate for schizophrenia and comorbid nicotine addiction: Current trends and perspectives.The NMDA receptor GluN2C subunit controls cortical excitatory-inhibitory balance, neuronal oscillations and cognitive function.The mGluR2 positive allosteric modulator, SAR218645, improves memory and attention deficits in translational models of cognitive symptoms associated with schizophreniaInhibition of 14-3-3 Proteins Leads to Schizophrenia-Related Behavioral Phenotypes and Synaptic Defects in Mice.Spontaneous Gamma Activity in Schizophrenia.Current and emergent treatments for symptoms and neurocognitive impairment in schizophrenia.Reversal of evoked gamma oscillation deficits is predictive of antipsychotic activity with a unique profile for clozapine.Targeting Glia with N-Acetylcysteine Modulates Brain Glutamate and Behaviors Relevant to Neurodevelopmental Disorders in C57BL/6J Mice.GluN2C/GluN2D subunit-selective NMDA receptor potentiator CIQ reverses MK-801-induced impairment in prepulse inhibition and working memory in Y-maze test in mice.Reduction in phencyclidine induced sensorimotor gating deficits in the rat following increased system xc⁻ activity in the medial prefrontal cortex.Mismatch negativity (MMN) and sensory auditory processing in children aged 9-12 years presenting with putative antecedents of schizophrenia.The effect of pregabalin on sensorimotor gating in 'low' gating humans and mice.Modeling resilience to schizophrenia in genetically modified mice: a novel approach to drug discovery.Somatosensory timing deficits in schizophreniaNeuromapping techniques in drug discovery: pharmacological MRI for the assessment of novel antipsychotics.Interneuron precursor transplants in adult hippocampus reverse psychosis-relevant features in a mouse model of hippocampal disinhibition.A role for D-aspartate oxidase in schizophrenia and in schizophrenia-related symptoms induced by phencyclidine in miceA negative feedback loop controls NMDA receptor function in cortical interneurons via neuregulin 2/ErbB4 signalling.The role of P2X7 receptors in a rodent PCP-induced schizophrenia model.
P2860
Q21089799-13CDD4CA-154B-4598-A09F-CB140C090483Q21129356-98FC85F6-559D-4CBC-89C5-611FA5234351Q21284720-3951A356-E7D0-45C6-AC0B-9EDAB2E062B7Q23913269-461A19E2-5E3C-4947-B99D-C4A03CBADCC0Q24561726-C8ACAF0F-3DCA-4D4A-B765-F287D7205E47Q26744718-3D05EC22-43ED-44CD-ABEC-1E07AEC2E04BQ26830603-BF86C71A-0793-4CE5-AFE3-E717333C92DAQ26995879-112EA613-1833-422C-B2D9-A8AA15DC860FQ26999303-F443EAE6-0067-4144-9201-D9F2CCBF0CD8Q27013753-C0A0A3C6-227E-4C1A-BDB1-9C5653B55347Q27023967-27976739-DFB2-45FD-80C1-A8F90924DA29Q27304814-45BA8200-9526-42C2-A628-800AB427B868Q27320104-ABA66516-91DB-4C89-9F92-420EC21E6331Q28073684-5867A1BF-1A03-4254-B5C0-38F8323C6CC6Q28270694-BD0F2E68-11D2-4B01-A68B-4CE49ED857C9Q28303840-A76519CC-74D2-452C-82DC-0939FADAAD24Q28511930-DABE9BFA-1AD2-4832-88FA-2B5DE95CC7EFQ28575579-DF1461EE-2098-495E-B025-4F4DF0D80A4DQ29541297-DA942CCC-34E9-4EA2-B645-94AEA9BFDBD7Q30244854-3BF9C6F2-C32D-4970-BF88-F83FC7A7C82FQ30251961-4CC0EA92-71CA-4234-B1AC-7F8EB1D29B77Q30362464-7A74494C-F4E9-45A5-9B98-90A6433F548FQ30367844-AC5A5EC7-54E8-4876-A0D6-E91AC1FAAFD5Q30371933-92CB4116-5962-4B27-B4B6-616ADE4922E3Q30374432-45DF8E67-49ED-4737-A2B3-528AA8C3FE3AQ30377860-CC321C96-024E-47C3-89E1-8EB584C952B8Q30382281-E8DA48D1-B912-4139-B8E4-2D32441B4BFAQ30383064-B098AABD-BE43-45B9-BA7E-BCC0E203A2B3Q30395471-06C9541F-2C1A-469C-9DB6-3E60F4B01258Q30419647-97FC76FD-25B5-4CFE-A0A1-60BE339085B3Q30440988-7C64974D-E4A5-4420-99F7-879BED02EA71Q30448022-9390F042-F0A1-4C88-9A50-0C72B6EC09DFQ30450055-2B5427B1-4AC5-4494-8BD9-B994637E3E3BQ30454958-537D12A8-1948-4D1C-9CE3-DED7C9509201Q30537875-7AB3DBC2-2708-4DCB-8012-506872D8BCEEQ30564474-0E87543D-73BA-483E-9D69-7C6019C6212CQ30578889-5A87CFB3-DA81-425E-9DE1-0AED7D7A5EC4Q30651885-6777F51C-21B4-419F-AE35-B12584608907Q30652639-FBAECA82-3217-448C-A89F-39D10A290D08Q30827880-F3AB87E5-8D82-4702-87B5-1E0737DCF953
P2860
From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment.
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
From revolution to evolution: ...... its implication for treatment.
@ast
From revolution to evolution: ...... its implication for treatment.
@en
From revolution to evolution: ...... its implication for treatment.
@nl
type
label
From revolution to evolution: ...... its implication for treatment.
@ast
From revolution to evolution: ...... its implication for treatment.
@en
From revolution to evolution: ...... its implication for treatment.
@nl
prefLabel
From revolution to evolution: ...... its implication for treatment.
@ast
From revolution to evolution: ...... its implication for treatment.
@en
From revolution to evolution: ...... its implication for treatment.
@nl
P2860
P356
P1476
From revolution to evolution: ...... its implication for treatment.
@en
P2860
P2888
P356
10.1038/NPP.2011.181
P407
P577
2011-09-28T00:00:00Z
P5875
P6179
1033820531